AstraZeneca's Brilinta faces judgment day, Telegraph reports
Rate:
40,069 ratings
Views: 805
From: TradeTheTrend
Added: 16 years ago · 0:44 · 480p
AstraZeneca (AZN) will face an expert panel on Wednesday to study clinical trial data on Brilinta, the company's new anti-clotting ...
Comments
No comments yet.